A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...
A new study finds that an experimental device implanted in the heart can relieve the chest pain of heart disease in people who aren't candidates for stents or surgery. Instead of opening up a blood ...
Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...
VANCOUVER - Neovasc Inc. ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally ...
VANCOUVER and MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced positive clinical data at the Transcatheter ...
VANCOUVER, British Columbia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
VANCOUVER, April 17, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback